Weekly-docetaxel chemotherapy for Taiwanese patients withmetastatic castrate-resistant prostate cancer

Lignende værker

• Serum creatinine for differentiating traumatic intraperitoneal and extraperitoneal bladder perforation
  af: Cheng-Li Kao, et al.
  Udgivet: (2015-06-01)
• Prediction for survival following docetaxel-based chemotherapy in Taiwanese men with castration-resistant metastatic prostate cancer
  af: Kai-Fu Yang, et al.
  Udgivet: (2015-12-01)
• Intravesical hyaluronic acid treatment may improve lower urinary tract symptoms caused by ketamine-associated cystitis: Preliminary result
  af: En Meng, et al.
  Udgivet: (2015-06-01)
• Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer
  af: KUME, HARUKI, et al.
  Udgivet: (2015)
• Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
  af: Francini, Filippo, et al.
  Udgivet: (2011)